,,iii  #aae? ,,congress  #b;d ,session  
,s4 ,,res4 #fjj  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,july #ca1 #bjah ,ms4 
,hirono 7= h]self & ,mr4 ,c>d97 submitt$
 ! foll[+ resolution2 :i* 0 ref]r$ to ! 
,committee on ,heal?1 ,education1       
,labor1 & ,p5sions  ,,resolution        
,recogniz+ ,july #bh1 #bjah1 z ,_w      
,hepatitis ,day4  ,:]eas hepatitis ,b1  
hepatitis ,c1 & ! incid5ce ( liv]       
disease caus$ by su* viruses h become   
urg5t problems ( a global proportion2   
,:]eas1 worldwide1 an e/imat$-- 7#a7    
#a1cdj1jjj p die ea* ye> due to         
hepatitis2  7#b7 #beg1jjj1jjj p live )  
*ronic hepatitis ,b2  7#c7 #hhg1jjj p   
die ea* ye> mo/ly due to a liv]-relat$  
illness caus$ by hepatitis ,b2  7#d7    
#ga1jjj1jjj p are *ronically infect$ )  
hepatitis ,c2 &  7#e7 #cii1jjj p die ea*
 ye> due to a liv]-relat$ illness caus$ 
by hepatitis ,c2  ,:]eas1 9 ! ,unit$    
,/ates1 an e/imat$-- 7#a7 #e1gjj1jjj p  
are infect$ ) hepatitis ,b or hepatitis 
,c2  7#b7 #b1bjj1jjj p are *ronically   

infect$ ) hepatitis ,b2 &  7#c7         
#c1ejj1jjj p are *ronically infect$ )   
hepatitis ,c2  ,:]eas ! ,c5t]s =        
,disease ,control & ,prev5tion 7ref]r$  
to 9 ?is preamble z ! ,,cdc7 e/imates t1
 9 #bjaf1 !re 7 #bj1ijj new acute       
hepatitis ,b infections & #da1bjj new   
acute hepatitis ,c infections 9 ! ,unit$
 ,/ates2 ,:]eas ! ,,cdc has f\nd        
significant increases 9 ! am\nt ( new   
hepatitis cases 9 ! ,unit$ ,/ates s9ce  
#bjaj1 includ+ a #c4e-;fold increase    
betwe5 #bjaj & #bjaf 9 report$ cases (  
acute hepatitis ,c infections2 ,:]eas   
*ronic viral hepatitis claims ?\s&s (   
lives ea* ye> 9 ! ,unit$ ,/ates1 ) an   
e/imat$ #ah1aec dea?s due to hepatitis  
,c 9 #bjaf2 ,:]eas1 betwe5 #bjae &      
#bjbj1 !re is e/imat$ to be             
#acf1jjj1jjj1jjj 9 hepatitis ,c drug    
sp5d+ f all pay]s1 & gov]nm5t pay]s w\ld
 fund #fa1jjj1jjj1jjj1 an e/imat$ #de   
p]c5t ( su* sp5d+2 ,:]eas an e/imat$ #hj
 p]c5t ( p ) acute hepatitis ,c d n h   
any symptoms2 ,:]eas ,african ,am]icans1

 ,asian ,am]icans1 ,pacific ,isl&]s1    
,lat9os1 ,native ,am]icans1 ,alaska     
,natives1 gay & bisexual m51 & p :o     
inject drugs intrav5\sly h high] rates (
 *ronic viral hepatitis infections 9 !  
,unit$ ,/ates ?an o!r gr\ps ( p2 ,:]eas 
,asian ,am]icans & ,pacific ,isl&]s be> 
! greate/ burd5 ( hepatitis ,b-relat$   
dea?s 9 ! ,unit$ ,/ates2 ,:]eas         
hepatitis ,c is #aj times m infecti\s   
?an human immunodefici5cy virus 7ref]r$ 
to 9 ?is preamble z 8,,hiv072 ,:]eas    
hepatitis ,b is #ej to #ajj times m     
infecti\s ?an ,,hiv2 ,:]eas an e/imat$  
#be p]c5t ( p :o live 9 ! ,unit$ ,/ates 
& are infect$ ) ,,hiv are also infect$ )
 hepatitis ,c2 ,:]eas1 :ile life        
expectancies = individuals infect$ )    
,,hiv h increas$ ) antiretroviral       
treatm5t1 liv] disease1 :i* is commonly 
relat$ to hepatitis ,b & hepatitis ,c   
infections1 has become ! mo/ common     
cause ( dea? among ,,hiv-infect$        
individuals t is n relat$ to acquir$    
immune defici5cy syndrome2 ,:]eas1      

despite ! fact t *ronic viral hepatitis 
is ! mo/ common blood-borne infection 9 
! ,unit$ ,/ates1 m ?an half ( ! p liv+ )
 hepatitis ,b & hepatitis ,c are unaw>e 
( _! infections2 ,:]eas hepatitis ,b is 
prev5table ?r\gh vacc9ation1 & bo?      
hepatitis ,b & hepatitis ,c are         
prev5table ) prop] public heal?         
int]v5tions1 includ+ programs t (f]     
access to /]ile injection equipm5t = p  
:o inject drugs intrav5\sly2 & ,:]eas ! 
goals ( ,_w ,hepatitis ,day on ,july    
#bh1 #bjah1 are to-- 7#a7 highlight !   
global nature ( *ronic viral hepatitis  
epidemics2  7#b7 recognize t hepatitis c
 be prev5t$ & elim9at$1 9 "p1 ?r\gh a   
compreh5sive public education & aw>5ess 
campaign design$ to id5tify ^? at risk  
=1 & liv+ )1 hepatitis2  7#c7 in=m      
pati5ts ab\t new treatm5ts t are        
available = hepatitis2 &  7#d7 help     
increase ! l5g? & quality ( life = p    
diagnos$ ) *ronic hepatitis ,b &        
hepatitis ,c infections3 ,n[1 !re=e1 be 
x  ,t ! ,s5ate-- 7#a7 recognizes ,_w    

,hepatitis ,day2  7#b7 supports broad   
access to hepatitis ,b & hepatitis ,c   
treatm5ts2  7#c7 supports rais+ aw>5ess 
( ! risks & consequ5ces ( undiagnos$    
*ronic hepatitis ,b & hepatitis ,c      
infections2 &  7#d7 calls = a robu/     
gov]nm5tal & public heal? response to   
protect ! heal? ( ! approximately       
#e1gjj1jjj p 9 ! ,unit$ ,/ates &        
#cbh1jjj1jjj p worldwide :o h hepatitis4